Your browser doesn't support javascript.
loading
The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees.
Jiang, Cherry; Wolf, Katherine; Kaakati, Rayan; Oh, Jessica; Yip, Allison T; Jonklaas, Jacqueline; Bianco, Antonio C; Laiteerapong, Neda; Ettleson, Matthew D.
Afiliação
  • Jiang C; Section of General Internal Medicine, University of Chicago, Chicago, Illinois.
  • Wolf K; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Kaakati R; Division of Rheumatology, Allergy, and Immunology, Department of Pediatrics, Univeristy of North Carolina, Chapel Hill, North Carolina.
  • Oh J; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Yip AT; Division of General Internal Medicine, University of California San Diego, San Diego, California.
  • Jonklaas J; Division of Endocrinology, Georgetown University Medical Center, Washington, District of Columbia.
  • Bianco AC; Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, Illinois.
  • Laiteerapong N; Section of General Internal Medicine, University of Chicago, Chicago, Illinois.
  • Ettleson MD; Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, Illinois. Electronic address: Matthew.Ettleson@bsd.uchicago.edu.
Endocr Pract ; 29(10): 787-793, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37549880
ABSTRACT

OBJECTIVE:

There is no universal approach to the management of subclinical hypothyroidism (SCH). This study was designed to determine the impact of patient characteristics on management decisions in SCH amongst physician faculty members and trainees.

METHODS:

An online survey was distributed to faculty members and medical trainees (ie, interns, residents, and fellows) at multiple academic medical centers. The survey included 9 clinical scenarios describing women with SCH with 5 management options sequenced from most "conservative" (no further treatment or monitoring) to most "aggressive" (treatment with levothyroxine).

RESULTS:

Of the 194 survey respondents, 95 (49.0%) were faculty members and 99 (51.0%) were trainees. Faculty members were more likely to report being "confident" or "very confident" in making the diagnosis of SCH compared to trainees (95.8% vs 46.5%, P < .001). Faculty members were also more likely to consider patient preference for treatment (60.0% vs 32.3%, P < .001). Among all respondents, the clinical factors that resulted in the highest predicted probability of treatment were hypothyroid symptoms (predicted probability [PP] 68.8%, 95% CI [65.7%-71.9%]), thyroid stimulating hormone >10 mIU/L in a 31-year-old (PP 63.9%, 95% CI [60.3%-67.3%]), and the desire for fertility (PP 52.2%, 95% CI [48.6%-56.0%]). In general, faculty members favored more aggressive treatment across all clinical scenarios.

CONCLUSION:

The presence of symptoms, thyroid stimulating hormone >10 mIU/L, and desire for fertility were most predictive of the decision to treat in SCH. In several clinical scenarios, both trainee and faculty decision-making demonstrated discordance with general SCH management principles.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipotireoidismo Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipotireoidismo Idioma: En Ano de publicação: 2023 Tipo de documento: Article